Zobrazeno 1 - 3
of 3
pro vyhledávání: '"S. J. Ballantyne"'
Publikováno v:
Clinical & Experimental Allergy. 41:1447-1455
Summary Background Interleukin (IL)-25 (IL-17E) is a potent inducer of the type-2 immune effector response. Previously we have demonstrated that a neutralizing anti-IL-25 antibody, given during the establishment of ovalbumin-specific lung allergy, ab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9290c96f20fb8136755b8ed6c4365393
https://doi.org/10.1111/j.1365-2222.2011.03806.x
https://doi.org/10.1111/j.1365-2222.2011.03806.x
Publikováno v:
Clinical & Experimental Allergy. 41:1012-1021
Summary Background Initial studies suggested that polymorphisms in Tim1 and Tim3 contribute to the development of airway hyperreactivity (AHR) in an acute mouse model of asthma. This was also mirrored in human genetic studies where polymorphisms in T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1dde24feb4074e5edb16647eb9f0a0f8
https://doi.org/10.1111/j.1365-2222.2011.03728.x
https://doi.org/10.1111/j.1365-2222.2011.03728.x
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 41(10)
Interleukin (IL)-25 (IL-17E) is a potent inducer of the type-2 immune effector response. Previously we have demonstrated that a neutralizing anti-IL-25 antibody, given during the establishment of ovalbumin-specific lung allergy, abrogates airways hyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e9506e53069078da738fc1583e6a061
https://pubmed.ncbi.nlm.nih.gov/21722219
https://pubmed.ncbi.nlm.nih.gov/21722219